Adipose tissue-derived autologous stem cell therapy (InGeneron)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAdipose tissue-derived autologous stem cell therapy (InGeneron)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCollagen modulators
TargetsCollagen
Therapy Area/IndicationsTendon InjuriesKnee InjuriesLeg Ulcer +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIngeneron Inc
China Registration ClassN/A

Develop Information

Active CompaniesIngeneron Inc
Inactive CompaniesN/A
Active IndicationsTendon InjuriesKnee InjuriesLeg Ulcer +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A